PRKD1
Serine/threonine-protein kinase D1
Also known as: KPCD1_HUMAN, PKC-mu, PKCM, PKD, PRKCM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15139
- Gene
- PRKD1
- Ensembl
- ENSG00000184304
- Chromosome
- 14
- Canonical length
- 912 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a serine/threonine protein kinase involved in many cellular processes, including Golgi body membrane integrity and transport, cell migration and differentiation, MAPK8/JNK1 and Ras pathway signaling, MAPK1/3 (ERK1/2) pathway signaling, cell survival, and regulation of cell shape and adhesion. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
912 residues, UniProt reviewed canonical sequence.
>Q15139|PRKD1
1 MSAPPVLRPP SPLLPVAAAA AAAAAALVPG SGPGPAPFLA PVAAPVGGIS FHLQIGLSRE
61 PVLLLQDSSG DYSLAHVREM ACSIVDQKFP ECGFYGMYDK ILLFRHDPTS ENILQLVKAA
121 SDIQEGDLIE VVLSASATFE DFQIRPHALF VHSYRAPAFC DHCGEMLWGL VRQGLKCEGC
181 GLNYHKRCAF KIPNNCSGVR RRRLSNVSLT GVSTIRTSSA ELSTSAPDEP LLQKSPSESF
241 IGREKRSNSQ SYIGRPIHLD KILMSKVKVP HTFVIHSYTR PTVCQYCKKL LKGLFRQGLQ
301 CKDCRFNCHK RCAPKVPNNC LGEVTINGDL LSPGAESDVV MEEGSDDNDS ERNSGLMDDM
361 EEAMVQDAEM AMAECQNDSG EMQDPDPDHE DANRTISPST SNNIPLMRVV QSVKHTKRKS
421 STVMKEGWMV HYTSKDTLRK RHYWRLDSKC ITLFQNDTGS RYYKEIPLSE ILSLEPVKTS
481 ALIPNGANPH CFEITTANVV YYVGENVVNP SSPSPNNSVL TSGVGADVAR MWEIAIQHAL
541 MPVIPKGSSV GTGTNLHRDI SVSISVSNCQ IQENVDISTV YQIFPDEVLG SGQFGIVYGG
601 KHRKTGRDVA IKIIDKLRFP TKQESQLRNE VAILQNLHHP GVVNLECMFE TPERVFVVME
661 KLHGDMLEMI LSSEKGRLPE HITKFLITQI LVALRHLHFK NIVHCDLKPE NVLLASADPF
721 PQVKLCDFGF ARIIGEKSFR RSVVGTPAYL APEVLRNKGY NRSLDMWSVG VIIYVSLSGT
781 FPFNEDEDIH DQIQNAAFMY PPNPWKEISH EAIDLINNLL QVKMRKRYSV DKTLSHPWLQ
841 DYQTWLDLRE LECKIGERYI THESDDLRWE KYAGEQGLQY PTHLINPSAS HSDTPETEET
901 EMKALGERVS ILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 5.4 nTPM
Expression across tissuesHPA
Tissue
- testis: 5.4 nTPM
- blood vessel: 4.6 nTPM
- prostate: 4.3 nTPM
- parathyroid gland: 3.8 nTPM
- seminal vesicle: 3.6 nTPM
- urinary bladder: 3.5 nTPM
Single-cell type
- prostatic glandular cells: 1,754 nCPM
- sertoli cells: 1,512 nCPM
- somatotrophs: 797 nCPM
- loop of henle epithelial cells: 766 nCPM
- podocytes: 723 nCPM
- distal convoluted tubule cells: 710 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 23 nTPM
- spinal cord: 21 nTPM
- medulla oblongata: 20 nTPM
- midbrain: 20 nTPM
- basal ganglia: 19 nTPM
- hypothalamus: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKD1.
Disease | AllUniProt
Conditions PRKD1 is implicated in, by any mechanism.
- Congenital heart defects and ectodermal dysplasia (CHDED) MIM:617364
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 266 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital heart defects and ectodermal dysplasia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- apoptotic process
- cell differentiation
- cellular response to amino acid starvation
- cellular response to angiotensin
- cellular response to endothelin
- cellular response to hydroperoxide
- cellular response to norepinephrine stimulus
- cellular response to oxidative stress
- cellular response to phorbol 13-acetate 12-myristate
- cellular response to vascular endothelial growth factor stimulus
- defense response to Gram-negative bacterium
- Golgi organization
- Golgi vesicle transport
- inflammatory response
- innate immune response
- integrin-mediated signaling pathway
- intracellular signal transduction
- negative regulation of endocytosis
- nervous system development
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of angiogenesis
- positive regulation of autophagy
- positive regulation of blood vessel endothelial cell migration
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell size
- positive regulation of endothelial cell chemotaxis
- positive regulation of endothelial cell migration
- positive regulation of endothelial cell proliferation
- positive regulation of gene expression
- positive regulation of neuron projection development
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of NLRP3 inflammasome complex assembly
- positive regulation of osteoblast differentiation
- positive regulation of peptide hormone secretion
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein export from nucleus
- positive regulation of protein import into nucleus
- positive regulation of sarcomere organization
- positive regulation of transcription by RNA polymerase II
- protein autophosphorylation
- regulation of integrin-mediated signaling pathway
- regulation of keratinocyte proliferation
- regulation of release of sequestered calcium ion into cytosol
- signal transduction
- sphingolipid biosynthetic process
- transepithelial transport
- vascular endothelial growth factor receptor signaling pathway
- regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril
Molecular functions
- ATP binding
- diacylglycerol-dependent serine/threonine kinase activity
- heat shock protein binding
- identical protein binding
- kinase activity
- phosphatidylinositol 3-kinase activator activity
- protein kinase C binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Pleckstrin homology domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- PH-like domain superfamily
- Protein kinase C mu-related
- Protein kinase, ATP binding site
- Diacylglycerol/phorbol-ester binding
- C1-like domain superfamily
- Serine/threonine-protein kinase D1-3-like, ubiquitin-like domain
- Protein kinase domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- PH domain
- Serine/threonine-protein kinase D1-like, ubiquitin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKD1 as an antibody target. Whether an autoantibody or antibody against PRKD1 could matter depends on whether native PRKD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKD1 is annotated at the cell surface, where native PRKD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PRKD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...